Skip to main content

Table 5 Mean hours spend in each functional state over 48-h

From: Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial

 

Mean (SD) hours in pain state

 

Complete case analysis

MNAR imputation analysis

Functional states

Zav (n  = 328)

PBO (n = 313)

Mean difference

Cohen’s D

P-value

Zav ( n = 623)

PBO (n = 646)

Mean difference

Cohen’s D

P-value

Normal

39.5 (11.8)

36.7 (14.5)

 + 2.8

0.212

0.007

31.9 (16.9)

28.2 (18.1)

 + 3.7

0.211

 < 0.001

Mildly impaired

6.5 (9.2)

8.8 (11.6)

 − 2.3

−0.227

0.006

12.3 (13.2)

15.1 (14.4)

 − 2.8

−0.207

 < 0.001

Severely impaired

1.1 (3.6)

1.9 (5.0)

 − 0.8

−0.184

0.032

2.4 (4.6)

3.4 (6.2)

 − 1

−0.183

0.001

Requires bedrest

0.9 (3.9)

0.7 (2.8)

 + 0.2

0.059

0.520

1.4 (4.3)

1.2 (3.3)

 + 0.2

0.052

0.469

  1. Abbreviations: MNAR missing not at random, PBO placebo, SD standard deviation, zav zavegepant